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Introduction
Regulatory T lymphocytes (Treg) play a critical role in control of immune responses. In experimental settings, these cells inhibit development of autoimmune responses and of inflammatory bowel disease, regulate immunity to the fetus and to tumors, and also control immunity to various infections (1) (2) (3) (4) (5) (6) . Moreover, when appropriately expanded in vitro, Treg can prevent allograft rejection as well as Graft-versus-Host Disease (7) . Whereas the repertoire of Treg must therefore contain cells specific for non-self antigens, it has been firmly established that it is enriched in autospecific cells. Our studies using limiting dilution analysis showed that in the CD4 + CD25 + Treg repertoire the frequency of autospecific cells is substantially higher than that of cells proliferating in response to allogeneic APC (8) . We therefore concluded that the Treg repertoire is exquisitely shaped to recognize self-antigens.
This conclusion was later elegantly confirmed by others (9) (10) (11) .
It is thought that most, though not all (12) (13) (14) (15) , CD4 + CD25 + Treg develop in the thymus (16) .
Moreover, data from our laboratory as well as from others, indicate that an autoreactive Treg repertoire is shaped in the thymus (11, 17) . Given the stringent selection processes developing T cell precursors are submitted to in this organ, it is of utmost importance to evaluate how the autospecific Treg repertoire develops intrathymically. To allow for development of an autoreactive repertoire, Treg precursors must be less susceptible to negative selection than precursors of conventional T cells (Tconv). In mice in which negative selection is generally defective, e.g. in certain transgenic or bone marrow chimeric mice, a strongly autospecific selection of Tconv is very MHC/peptide specific and appears to be mediated by non-agonist self-ligands (21). By contrast, Treg precursors with high avidity for self-MHC/peptide ligands may be preferentially selected, thus contributing to shaping of the autoreactive Treg repertoire.
Initially, thymic selection of Treg was studied using TCR/ligand doubly transgenic mice (22) (23) (24) (25) (26) (27) 
Materials and Methods

Mice
In vitro proliferation and inhibition-of-proliferation tests
Functional limiting dilution analysis
Titrated numbers (0-400) of purified CD4 + CD25 + thymocytes were cultured in 96-well plates (48 wells/condition) containing 5. 
Results
Generation and characterization of transgenic mice expressing a single MHC class II/peptide ligand by cTEC
To study the potential role of agonist ligands in positive selection of T lymphocytes from precursors with a normally diverse TCR repertoire, we generated mice in which a single MHC class II/peptide ligand is expressed on positively selecting thymic stromal cells, i.e. positively selects regulatory T cells from a precursor population with a normally diverse TCR repertoire.
To consolidate these results, we also performed more conventional in vitro inhibition-ofproliferation assays using splenic Treg from transgenic mice. Titrated numbers of TgIAβ°Ii + Treg were cultured in presence of B10.Q APC, the bCII or a control peptide, and allogeneic CD4 + CD25 -responder T cells. Similar inhibition curves were reproducibly obtained in absence and in presence of the bCII peptide (Fig. 4D) . Again, inhibition was at least in part due to defective negative selection in our transgenic mice. By contrast, TgIAβ°Ii° Treg inhibited T cell proliferation substantially more efficiently in presence than in absence of specific bCII peptide (Fig. 4E ).
We also assessed splenic Treg activation by measuring their proliferation in response to IA qexpressing APC presenting bCII or control peptide in presence of high concentrations of IL-2.
As shown in figures 4F and H, Treg from TgIAβ°Ii + mice proliferated in response to APC expressing IA q (because of defective negative selection), but addition of bCII or control peptide did not modify this proliferation. By contrast, addition of bCII peptide led to increased proliferation of Treg from TgIAβ°Ii° mice, whereas addition of control peptide had no effect (Figs. 4G and H) .
In contrast to the observed preferential specificity of Treg for the positively selecting I-A q /bCII ligand, in proliferation assays we failed to observe any evidence that the repertoire of This is an author-produced version of a manuscript accepted for publication in The Journal of Immunology (The JI). The American Association of Immunologists, Inc. (AAI), publisher of The JI, holds the copyright to this manuscript. This manuscript has not yet been copyedited or subjected to editorial proofreading by The JI; hence it may differ from the final version published in The JI (online and in print). AAI (The JI) is not liable for errors or omissions in this author-produced version of the manuscript or in any version derived from it by the United States National Institutes of Health or any other third party. The final, citable version of record can be found at www.jimmunol.org.
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